Free Trial

Cardlytics (CDLX) Stock Price, News & Analysis

Cardlytics logo
$1.06 +0.03 (+2.91%)
Closing price 04:00 PM Eastern
Extended Trading
$1.07 +0.01 (+0.94%)
As of 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cardlytics Stock (NASDAQ:CDLX)

Key Stats

Today's Range
$1.05
$1.11
50-Day Range
$1.01
$3.12
52-Week Range
$0.95
$5.25
Volume
437,604 shs
Average Volume
1.52 million shs
Market Capitalization
$56.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.25
Consensus Rating
Moderate Buy

Company Overview

Cardlytics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

CDLX MarketRank™: 

Cardlytics scored higher than 76% of companies evaluated by MarketBeat, and ranked 86th out of 316 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardlytics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cardlytics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cardlytics' stock forecast and price target.
  • Earnings Growth

    Earnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardlytics is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardlytics is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cardlytics has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cardlytics' valuation and earnings.
  • Percentage of Shares Shorted

    12.65% of the float of Cardlytics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in Cardlytics has recently increased by 0.31%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Cardlytics does not currently pay a dividend.

  • Dividend Growth

    Cardlytics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.65% of the float of Cardlytics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in Cardlytics has recently increased by 0.31%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Cardlytics has a news sentiment score of 1.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.05 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cardlytics this week, compared to 5 articles on an average week.
  • Search Interest

    3 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $187,768.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of Cardlytics is held by insiders.

  • Percentage Held by Institutions

    68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardlytics' insider trading history.
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDLX Stock News Headlines

Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …tc pixel
Cardlytics (CDLX) Q2 Users Jump 19%
Cardlytics Reports Q2 2025 Financial Results
See More Headlines

CDLX Stock Analysis - Frequently Asked Questions

Cardlytics' stock was trading at $3.71 on January 1st, 2025. Since then, CDLX stock has decreased by 71.4% and is now trading at $1.06.

Cardlytics, Inc. (NASDAQ:CDLX) posted its quarterly earnings data on Wednesday, November, 6th. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.33) by $0.18. The firm's revenue was down 15.1% on a year-over-year basis.
Read the conference call transcript
.

Cardlytics subsidiaries include Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

Cardlytics (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Cardlytics' top institutional investors include Lane Generational LLC (1.49%), Geode Capital Management LLC (1.20%), Acorn Financial Advisory Services Inc. ADV (0.62%) and Wolverine Asset Management LLC. Insiders that own company stock include Clifford Sosin, Amit Gupta, Karim Saad Temsamani, Scott D Grimes, Alexis Desieno, Nicholas Hollmeyer Lynton, Andrew Christiansen and John V Balen.
View institutional ownership trends
.

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS).

Company Calendar

Last Earnings
11/06/2024
Today
8/28/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Services
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CDLX
CIK
1666071
Fax
N/A
Employees
500
Year Founded
2008

Price Target and Rating

High Price Target
$2.50
Low Price Target
$2.00
Potential Upside/Downside
+112.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$189.30 million
Net Margins
-68.87%
Pretax Margin
-68.87%
Return on Equity
-279.39%
Return on Assets
-48.17%

Debt

Debt-to-Equity Ratio
2.87
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
$278.30 million
Price / Sales
0.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.10 per share
Price / Book
0.96

Miscellaneous

Outstanding Shares
53,240,000
Free Float
50,895,000
Market Cap
$56.43 million
Optionable
Optionable
Beta
1.26

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:CDLX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners